WST · West Pharmaceutical Services Inc
Market Cap
$24.12B
Shares
70.38M
WST metrics
94 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$339.97
Market cap
$24.12B
Price action
19 metricsPrice change (1W)
-1.0%
Price change (30D)
-1.7%
Price change (3M)
+8.0%
Price change (6M)
+40.3%
Price change (YTD)
+24.6%
Price change (1Y)
+37.7%
Trailing year
Price change (5Y)
-26.2%
52-week high
$365.74
52-week low
$230.95
Change from 52-week high
-6.3%
Change from 52-week low
+48.4%
Annualized volatility
33.8%
Beta
0.7
RSI (14D)
45.8
Price vs SMA 50
-2.1%
Price vs SMA 200
+16.8%
Avg volume (3M)
697,629
Relative volume
0.4
Average dollar volume
$240.39M
Company
3 metricsSector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
70.38M
Valuation
12 metricsP / E (TTM)
43.9
Trailing earnings · reciprocal yield 2.3%
PEG ratio
2.4
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
7.3×
reciprocal yield 13.8%
P / book
8.1
reciprocal yield 12.4%
FCF yield
1.8%
TTM · current market cap
Buyback yield
1.9%
P / FCF
55.2
reciprocal yield 1.8%
P / operating cash flow
36.4
reciprocal yield 2.7%
Earnings yield
2.3%
Historical valuation
8 metricsP / E historical average (3Y)
42.5×
reciprocal yield 2.4%
P / E historical average (5Y)
42.7×
reciprocal yield 2.3%
EV / revenue historical average (3Y)
7.2×
reciprocal yield 13.9%
EV / revenue historical average (5Y)
7.9×
reciprocal yield 12.7%
EV / EBIT historical average (3Y)
34.7×
reciprocal yield 2.9%
EV / EBIT historical average (5Y)
34.8×
reciprocal yield 2.9%
EV / EBITDA historical average (3Y)
26.5×
reciprocal yield 3.8%
EV / EBITDA historical average (5Y)
26.5×
reciprocal yield 3.8%
Dividends & buybacks
7 metricsDividend yield
0.3%
Trailing 12 months
Payout ratio
11.0%
Shareholder yield
2.1%
Dividend / share (TTM)
$0.88
Dividend growth YoY
+4.8%
Dividend growth streak
5
Last ex-dividend
2026-07-29
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-23
Profitability
9 metricsGross margin
36.8%
Operating margin
20.5%
Trailing 12 months
Net margin
17.0%
Gross profit (TTM)
$1.22B
Operating profit (TTM)
$680.40M
Net income (TTM)
$564.90M
Trailing 12 months
Diluted EPS (TTM)
$7.81
FCF margin
13.1%
Effective tax rate
20.8%
Growth
11 metricsRevenue growth YoY
+13.8%
Year over year
Net income growth YoY
+16.8%
Revenue (TTM)
$3.33B
Trailing 12 months
EPS growth YoY
+18.1%
Shares change YoY
-1.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.1%
Revenue CAGR (5Y)
+7.4%
EPS CAGR (3Y)
-4.2%
EPS CAGR (5Y)
+8.2%
FCF CAGR (3Y)
+2.2%
FCF CAGR (5Y)
+9.5%
Quality
14 metricsReturn on equity
18.9%
Return on assets
13.9%
Debt / equity
0.1
Current ratio
2.8
EBITDA (TTM)
$861.80M
Free cash flow (TTM)
$436.90M
Quick ratio
2.1
Interest coverage
151.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$435.80M
Total assets
$4.08B
Total debt
$202.90M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$662.20M
Capital expenditures (TTM)
$225.30M
R&D (TTM)
$74.40M
SG&A (TTM)
$426.80M
Stock compensation (TTM)
$32.60M
R&D / revenue
2.2%
Stock compensation / revenue
1.0%
Ownership (13F)
3 metrics13F filers
832
13F filer change QoQ
+74
Institutional ownership
100.5%
Short interest
3 metricsShort interest
3.0%
Latest settlement · 4.1 days to cover
Days to cover
4.1d
Short-squeeze score
51 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—